Painless Haematuria: Suspected Bladder Cancer

Clinical Scenario

Robert Davies, 68, books an urgent video consultation for blood in his urine. He has noticed visible red-coloured urine for 3 days with no pain. He has no dysuria, frequency, or fever. He has a 45-pack-year smoking history (quit 5 years ago), worked in a chemical and dye manufacturing factory for 40 years, and his brother died of bladder cancer 3 years ago. PMH includes type 2 diabetes (diet controlled), hypertension, and BPH on tamsulosin.

What This Case Tests

Recognising painless macroscopic haematuria as a red flag for urological malignancy; identifying multiple bladder cancer risk factors (smoking, occupational exposure, family history, male sex, age); initiating an urgent 2-week wait suspected cancer referral; differentiating urological cancer presentation from UTI and BPH; communicating the need for urgent investigation without causing panic.

Common Mistakes Trainees Make

The three most common mistakes are: attributing the haematuria to the known BPH without urgent investigation (painless macroscopic haematuria is cancer until proven otherwise, regardless of existing urological conditions), treating empirically for UTI without evidence of infection (no dysuria, frequency, or fever makes UTI very unlikely), and not recognising the occupational exposure as a significant bladder cancer risk factor.

The Consultation Challenge

Painless visible haematuria in a 68-year-old man is a red flag for urological malignancy — most commonly bladder cancer. Robert has multiple risk factors that increase the pre-test probability significantly: 45-pack-year smoking history (the strongest risk factor for bladder cancer), 40 years of occupational exposure to chemicals and dyes (aromatic amines are established bladder carcinogens), a first-degree relative who died of bladder cancer, male sex (3:1 male predominance), and age over 60.

This requires an urgent 2-week wait suspected cancer referral. There is no ambiguity.

Take a focused history. Characterise the haematuria: timing (throughout stream suggests bladder or upper tract origin; terminal suggests bladder neck/prostate), colour (bright red versus dark/clot), duration, any associated symptoms, and any precipitating factors. Critically, exclude infection symptoms (no dysuria, frequency, or fever makes UTI very unlikely) and renal colic (no loin pain).

Assess the risk factors systematically. Smoking history (quantify in pack-years), occupational exposure (chemical, dye, rubber, or plastics industry — all carry bladder cancer risk), family history (brother died of bladder cancer), and existing urological history (BPH is present but does not explain painless haematuria and should not be used to defer investigation).

Initiate the 2WW referral. Per NICE NG12, all patients aged 45+ with unexplained visible haematuria without UTI should be referred urgently on the suspected cancer pathway. Robert meets this criterion clearly. The referral should be submitted today — electronic referral via e-RS marked as urgent suspected urological cancer.

Communicate sensitively. Robert may not have connected the haematuria to cancer risk. Be honest without being alarmist: "Blood in the urine without pain always needs to be investigated urgently. In most cases, we find a benign cause, but given your smoking history and your brother's experience, I want to make sure we get this checked as quickly as possible."

Arrange interim investigations: urine dipstick and MC&S (to document haematuria and exclude infection), FBC, U&Es, and eGFR. These do not delay the referral — they supplement it.

Time check: Spend the first 3 minutes on the haematuria history and symptom assessment. By minute 5, identify the risk factors and make the clinical assessment. Explain the 2WW referral between minutes 6-8 with honest but measured communication. Use the remaining time for interim investigations, practical advice, and emotional support.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you characterise the haematuria thoroughly, exclude infection (absence of dysuria, frequency, fever), screen for systemic symptoms (weight loss, bone pain), and identify the full spectrum of bladder cancer risk factors. A trainee who identifies smoking but misses the occupational exposure and family history will lose marks. The diagnostic assessment should be clear and decisive: this is a suspected cancer referral.

Clinical Management and Medical Complexity: Examiners expect an immediate 2WW referral with no delay. They look for knowledge of the NICE NG12 pathway, understanding that BPH does not explain painless haematuria and should not defer investigation, and appropriate interim investigations. A trainee who prescribes antibiotics, orders a PSA, or arranges a routine urology appointment will score very poorly.

Relating to Others: Examiners assess whether you communicate the need for urgent investigation honestly but without causing panic, acknowledge the family history sensitively (his brother died of this cancer), and provide emotional support. Robert should leave understanding why the referral is urgent and what to expect next.

Example Opening

Strong opening: "Hello Robert, I can see you've noticed blood in your urine. Thank you for calling urgently — this is absolutely the right thing to do. Can you tell me exactly what you've been seeing, and whether you've had any pain or other symptoms?"

When explaining the referral: "Painless blood in the urine in someone your age always needs to be investigated quickly. I want to be upfront with you — given your smoking history and that your brother had bladder cancer, I want to get you seen by a specialist within 2 weeks. This doesn't mean you have cancer, but it means we need to rule it out properly and not wait."

Avoid: "It could just be your prostate playing up." (Dangerous false reassurance that could delay cancer diagnosis).

How This Appears in the SCA

Painless macroscopic haematuria is one of the clearest cancer red flags in the SCA. The examiner is testing whether you recognise the urgency, identify the risk factors, initiate the correct referral pathway immediately, and communicate this to the patient. There should be no hesitation or delay.

Key Statistic

Bladder cancer is the 10th most common cancer in the UK, with approximately 10,000 new cases annually. Smoking accounts for approximately 50% of bladder cancer cases. Occupational exposure to aromatic amines (chemical, dye, rubber industry) is the second most common risk factor. Early detection significantly improves prognosis — 5-year survival for stage 1 bladder cancer exceeds 85%.

Relevant Guidelines

• NICE NG12: Suspected cancer — recognition and referral
• NICE guideline on bladder cancer
• British Association of Urological Surgeons (BAUS) guidance on haematuria.

Frequently Asked Questions

Is all visible haematuria a 2-week wait referral?

NICE NG12 recommends urgent 2WW referral for all patients aged 45+ with unexplained visible haematuria without UTI. For patients under 45, visible haematuria should still be investigated but may follow a less urgent pathway depending on the clinical picture. Non-visible (microscopic) haematuria in patients aged 60+ with dysuria or raised white cell count also warrants 2WW referral. The key principle: all visible haematuria requires investigation — never assume it is benign without assessment.

Can BPH explain painless haematuria?

BPH can cause haematuria, but painless macroscopic haematuria in a patient with bladder cancer risk factors must not be attributed to BPH without urological investigation. Co-existing BPH does not reduce the cancer risk and should not be used to defer the 2WW referral. The specialist will determine the source of bleeding through cystoscopy and imaging — this is not a primary care decision.

What occupational exposures increase bladder cancer risk?

Aromatic amines are the key carcinogens. High-risk occupations include: chemical and dye manufacturing, rubber industry, leather work, painting, printing, hairdressing (historical exposure to certain dyes), and aluminium production. The latency period between exposure and cancer can be 20-40 years, meaning retired workers remain at risk. Robert's 40-year career in chemical and dye manufacturing represents a significant occupational risk that should be highlighted in the referral.

How do I differentiate UTI from bladder cancer presenting with haematuria?

UTI typically presents with dysuria, urinary frequency, urgency, and sometimes fever — alongside the haematuria. Bladder cancer typically presents with painless haematuria without infective symptoms. The absence of pain is a key distinguishing feature. However, the two can co-exist, and UTI should not be used to explain haematuria in a high-risk patient. If in doubt, treat the UTI and re-check — if haematuria persists after infection clearance, refer urgently.

What happens after a 2-week wait referral for haematuria?

The patient will be seen within 14 days. Standard investigation includes: flexible cystoscopy (direct visualisation of the bladder lining — the gold standard for bladder cancer detection), CT urogram (imaging of the upper urinary tract — kidneys and ureters), and blood tests. The GP's role is to make the referral promptly, communicate the rationale to the patient, and provide interim support while awaiting the appointment.